Harris AL - Search Results

1

Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer.

Ghazoui Z, Buffa FM, Dunbier AK, Anderson H, Dexter T, Detre S, Salter J, Smith IE, Harris AL, Dowsett M. Ghazoui Z, et al. Among authors: harris al. Clin Cancer Res. 2011 May 1;17(9):3005-12. doi: 10.1158/1078-0432.CCR-10-1704. Epub 2011 Feb 15. Clin Cancer Res. 2011. PMID: 21325071

2

Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.

Dowsett M, Mehta A, Cantwell BM, Harris AL. Dowsett M, et al. Among authors: harris al. Eur J Cancer. 1991;27(7):846-9. doi: 10.1016/0277-5379(91)90131-v. Eur J Cancer. 1991. PMID: 1657077

3

Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.

Millward MJ, Cantwell BM, Dowsett M, Carmichael J, Harris AL. Millward MJ, et al. Among authors: harris al. Br J Cancer. 1991 May;63(5):763-4. doi: 10.1038/bjc.1991.170. Br J Cancer. 1991. PMID: 1903951 Free PMC article. Clinical Trial. No abstract available.

4

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.

Harris AL, Carmichael J, Cantwell BM, Dowsett M. Harris AL, et al. Br J Cancer. 1989 Jan;59(1):97-9. doi: 10.1038/bjc.1989.19. Br J Cancer. 1989. PMID: 2527049 Free PMC article.

5

Endocrinology of Zoladex in postmenopausal women.

Dowsett M, Cantwell BM, Harris AL. Dowsett M, et al. Among authors: harris al. Horm Res. 1989;32 Suppl 1:209-12. doi: 10.1159/000181348. Horm Res. 1989. PMID: 2533152

6

Zoladex: therapeutic effects in postmenopausal breast cancer.

Harris AL, Carmichael J, Cantwell BM, Dowsett M. Harris AL, et al. Horm Res. 1989;32 Suppl 1:213-6; discussion 217. doi: 10.1159/000181349. Horm Res. 1989. PMID: 2533153

7

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.

Dowsett M, Harris AL, Stuart-Harris R, Hill M, Cantwell BM, Smith IE, Jeffcoate SL. Dowsett M, et al. Among authors: harris al. Br J Cancer. 1985 Oct;52(4):525-9. doi: 10.1038/bjc.1985.223. Br J Cancer. 1985. PMID: 2933050 Free PMC article.

8

Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin.

Dowsett M, Cantwell B, Lal A, Jeffcoate SL, Harris AL. Dowsett M, et al. Among authors: harris al. J Clin Endocrinol Metab. 1988 Apr;66(4):672-7. doi: 10.1210/jcem-66-4-672. J Clin Endocrinol Metab. 1988. PMID: 2964454

9

High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.

Harris AL, Cantwell BM, Dowsett M. Harris AL, et al. Br J Cancer. 1988 Oct;58(4):493-6. doi: 10.1038/bjc.1988.247. Br J Cancer. 1988. PMID: 2974717 Free PMC article.

10

Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.

Stuart-Harris R, Dowsett M, D'Souza A, Donaldson A, Harris AL, Jeffcoate SL, Smith IE. Stuart-Harris R, et al. Among authors: harris al. Clin Endocrinol (Oxf). 1985 Feb;22(2):219-26. doi: 10.1111/j.1365-2265.1985.tb01083.x. Clin Endocrinol (Oxf). 1985. PMID: 2985301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,286 results

Search Page

Filters